Cite
[Use of metacortandracin and 9-alpha-fluorohydrocortisone acetate in rheumatic diseases].
MLA
Ballabio, C. B., et al. “[Use of Metacortandracin and 9-Alpha-Fluorohydrocortisone Acetate in Rheumatic Diseases].” Reumatismo, vol. 7, no. 3, May 1955, pp. 113–26. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=14395568&authtype=sso&custid=ns315887.
APA
Ballabio, C. B., Amira, A., Cirla, E., & Sala, G. (1955). [Use of metacortandracin and 9-alpha-fluorohydrocortisone acetate in rheumatic diseases]. Reumatismo, 7(3), 113–126.
Chicago
Ballabio, C B, A Amira, E Cirla, and G Sala. 1955. “[Use of Metacortandracin and 9-Alpha-Fluorohydrocortisone Acetate in Rheumatic Diseases].” Reumatismo 7 (3): 113–26. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=14395568&authtype=sso&custid=ns315887.